JNCCN 360

Advertisement

Advertisement

Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Expert Perspective

Ian W. Flinn, MD, PhD, on Chronic Lymphocytic Leukemia: Early-Phase Research on Immunotherapy

Anthony J. Olszanski, MD, RPh, on Cutaneous Melanoma: Adjuvant Systemic Therapy

Recent

EHA25 Virtual: Does Administration Sequence of Ibrutinib/Obinutuzumab in CLL Affect Toxicity?

AACR II: Early Results With Dual Inhibitors of IGF and CDK4/6 in Lung Cancer

AACR II: Adding Interferon-Gamma to Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer

Idecabtagene Vicleucel for Relapsed or Refractory Multiple Myeloma

Published

Medical Literature

Is Proteome Instability a Treatment Opportunity in Mismatch Repair–Deficient Colorectal Cancers?

Tumor-Infiltrating Lymphocytes in Metastatic Lung Cancer

Upfront FOLFOXIRI Plus Bevacizumab in Metastatic Colorectal Cancer: TRIBE2 Trial Update

Measles Virus Vaccine Under Study in Multiple Myeloma

Ongoing

Modest Responses With Immunotherapy Combo for Advanced Ovarian Cancer

Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy

BCOP Test-Advances in Targeted Therapy and Immunotherapy For The Treatment of Kidney Cancer

NCCN Pharmacy Updates: Advances in Targeted Therapy and Immunotherapy for the Treatment of Kidney Cancer

Available

Clinical Trials

ClinicalTrials.gov Immunotherapy

Center for Immunotherapy Clinical Research Trials

Cancer Research Institute Immunotherapy Clinical Trials

Immunotherapy Clinical Trials at Fred Hutch Cancer Research Center

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.